Want to see TSE:AVCR full AI Analyst Report?
Avricore Health (AVCR) Stock Statistics & Valuation Metrics
Total Valuation
Avricore Health has a market cap or net worth of CAD 6.32M. The enterprise value is CAD 5.89M.
- Market Cap
- CAD 6.32M
- Enterprise Value
- CAD 5.89M
Share Statistics
Avricore Health has 126,369,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 126,369,670
- Owned by Insiders
- 7.46%
- Owned by Institutions
- ―
Financial Efficiency
Avricore Health’s return on equity (ROE) is -4.77 and return on invested capital (ROIC) is -351.04%.
- Return on Equity (ROE)
- -4.77
- Return on Assets (ROA)
- -3.30
- Return on Invested Capital (ROIC)
- -351.04%
- Return on Capital Employed (ROCE)
- -3.51
- Revenue Per Employee
- 20.53K
- Profits Per Employee
- -71.49K
- Employee Count
- 26
- Asset Turnover
- 0.95
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Avricore Health is -2.84. Avricore Health’s PEG ratio is 0.12.
- PE Ratio
- -2.84
- PS Ratio
- 32.73
- PB Ratio
- 4.73
- Price to FCF
- -5.61
- Price to Operating Cash Flow
- -4.75
- PEG Ratio
- 0.12
Income Statement
In the last 12 months, Avricore Health had revenue of 533.88K and earned -1.86M in profits. Earnings per share was -0.02.
- Revenue
- 533.88K
- Gross Profit
- 236.33K
- Operating Income
- -1.37M
- Pretax Income
- -1.86M
- Net Income
- -1.86M
- EBITDA
- -1.23M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -1.10M and capital expenditures -22,944, giving a free cash flow of -1.13M billion.
- Operating Cash Flow
- -1.10M
- Free Cash Flow
- -1.13M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Avricore Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -17.84%
- Earnings Yield
- -34.38%
Stock Price Statistics
- Beta
- 1.31
- 52-Week Price Change
- -9.09%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.06
- Relative Strength Index (RSI)
- 43.59
- Average Volume (3m)
- 61.82K
Important Dates
Avricore Health upcoming earnings date is Nov 26, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 01, 2026
- Next Earnings Date
- Nov 26, 2026
- Ex-Dividend Date
- ―
Financial Position
Avricore Health as a current ratio of 2.11, with Debt / Equity ratio of 0.00%
- Current Ratio
- 2.11
- Quick Ratio
- 2.11
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.19
- Interest Coverage Ratio
- -151.48
Taxes
In the past 12 months, Avricore Health has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Avricore Health EV to EBITDA ratio is -4.40, with an EV/FCF ratio of -4.80.
- EV to Sales
- 28.00
- EV to EBITDA
- -4.40
- EV to Free Cash Flow
- -4.80
- EV to Operating Cash Flow
- -4.90
Balance Sheet
Avricore Health has CAD 922.55K in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of CAD 922.55K billion.
- Cash & Marketable Securities
- CAD 922.55K
- Total Debt
- CAD 0.00
- Net Cash
- CAD 922.55K
- Net Cash Per Share
- CAD 0.01
- Tangible Book Value Per Share
- CAD 0.01
Margins
Gross margin is -36.75%, with operating margin of -677.30%, and net profit margin of -933.80%.
- Gross Margin
- -36.75%
- Operating Margin
- -677.30%
- Pretax Margin
- -933.80%
- Net Profit Margin
- -933.80%
- EBITDA Margin
- -635.99%
- EBIT Margin
- -676.10%
Analyst Forecast
The average price target for Avricore Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -93.73%
- EPS Growth Forecast
- -25.53%
Scores
- Smart Score
- ―
- AI Score
- 44